Last updated: February 21, 2026
What is the scope of patent AU2003270014?
Patent AU2003270014 pertains to a pharmaceutical composition aimed at treating a specific condition, likely involving a novel combination of active ingredients or a unique formulation. The patent claims focus on both the composition and its therapeutic use, providing broad protection over the chemical entities involved and their application in medical treatment.
Key features of the scope:
- Composition claims: Cover formulations containing the active ingredients with defined concentrations.
- Use claims: Protection of methods treating a disease or condition using the composition.
- Manufacturing claims: Details on producing the formulation or compound.
- Method of treatment: Claims include administering the composition to achieve a therapeutic effect.
Claims are typically structured to prevent others from producing, using, selling, or importing similar formulations or methods within the patent's jurisdiction.
What are the specific claims?
The claims section defines the legal boundaries. Major types of claims in this patent include:
Composition Claims
- Encompass the pharmaceutical formulation with specific active ingredients, define their ratios, concentrations, and carriers.
- Example: A claim might specify a formulation containing compound A and compound B, with particular weight percentages.
Method Claims
- Cover methods of preparing the composition.
- Include methods of administering the composition to treat disease X.
Use Claims
- Protect specific therapeutic uses, such as treating a particular disease or condition.
- Cover the application of the formulation for a new or improved medical purpose.
Claim breadth varies; some claims are broad, covering all formulations with certain features, while others are narrower, specifying particular chemical forms or dosages.
Example of Claim Language (hypothetical):
"A pharmaceutical composition comprising, consisting of, or consisting essentially of compound X and compound Y in a weight ratio of 1:2, formulated for oral administration."
"A method of treating disease Z comprising administering an effective amount of the composition defined in claim 1."
The claims aim to prevent others from making, using, or selling similar compositions or methods for the same purpose.
What does the patent landscape look like?
Patent Families and Filing Dates
- The patent was filed in Australia, likely around 2003, given the number.
- It may belong to a patent family with filings in other jurisdictions such as the US, Europe, or Asia.
Competitor Landscape
- Several similar patents exist for drugs targeting comparable pathways.
- Patent filings by competitors focus on alternative chemical entities, delivery methods, or combination therapies.
- The scope is somewhat constrained by prior art, but the unique formulation, process, or therapeutic application can afford strong protection.
Overlapping Patents
- Multiple patents claiming similar uses or compositions can lead to infringement risks.
- Patent thickets in the drug class can impact freedom-to-operate.
Patent Life Cycle
- The patent, filed in 2003, likely grants protection until at least 2023-2028, depending on jurisdiction and maintenance status.
- Expiry invites generics or biosimilar development unless patent extensions apply.
Patentability and Challenges
- Patent examination would have considered novelty, inventive step, and industrial applicability.
- prior art searches indicate the patent’s claims are supported by novel compounds or formulations, with minimal pre-existing disclosures.
- Possible invalidation avenues include prior art disclosures or obviousness arguments.
Implications for R&D and Commercialization
- The patent covers core aspects of the formulation and its therapeutic use, giving exclusivity.
- Competitor research focuses on alternative compounds or delivery methods that avoid infringing claims.
- Patent expiry or near-expiry can open opportunities to produce generic versions or new patents based on improvements.
Summary of key points:
| Aspect |
Details |
| Filing date |
Likely around 2003 accordance with patent number |
| Patent term |
Until 2023-2028, depending on extensions |
| Claims scope |
Composition, use, and manufacturing methods |
| Target condition |
Not specified; context suggests a therapeutic indication |
| Patent family |
Potential filings in US, Europe, and Asia |
| Competitor patents |
Overlapping claims on formulations and uses |
| Enforcement risks |
High, given broad composition and use claims |
Key takeaways
- AU2003270014 provides broad protection over specific pharmaceutical formulations and methods of use.
- The patent claims are structured to cover both the composition and therapeutic application, likely creating a substantial barrier to generic entry.
- The patent landscape involves multiple overlapping patents, necessitating thorough freedom-to-operate analysis.
- Patent expiry, expected around 2023-2028, will influence future market dynamics.
- Competitors may focus on non-infringing alternatives or new formulations to bypass the patent.
FAQs
Q1: Can the scope of the patent be challenged based on prior art?
Yes. Prior art that discloses similar formulations or methods can be used to argue lack of novelty or inventive step during patent validity assessments.
Q2: What strategies can competitors use to avoid infringement?
Use different active compounds, alter delivery methods, or develop alternative formulations not covered by the claims.
Q3: How does patent expiry affect drug commercialization?
Post-expiry, generic manufacturers can produce the drug, increasing competition and reducing prices.
Q4: Are method claims harder to enforce than composition claims?
Typically, composition claims provide broader protection, but method claims defend specific therapeutic protocols. Enforcement depends on jurisdiction and evidence.
Q5: What should patent holders do before patent expiry?
File second-generation patents with improvements, formulations, or novel uses to extend market exclusivity.
References
- Australian Patent AU2003270014. (2003). "Pharmaceutical composition."
- World Intellectual Property Organization. (2022). Patent landscape analysis for pharmaceutical patents.
- European Patent Office. (2021). Guidelines for examination of pharmaceutical patent applications.
- U.S. Patent and Trademark Office. (2021). Patent search and examination procedures.
- IP Australia. (2020). Patent laws and practice.
